{
    "startDate": "2020-01-01",
    "endDate": "2020-09-30",
    "year": "2020",
    "quarter": "Q3",
    "symbol": "INO",
    "data": {
        "bs": [
            {
                "label": "Fixed assets, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 11190521
            },
            {
                "label": "Investment in affiliated entities",
                "concept": "EquitySecuritiesFvNi",
                "unit": "usd",
                "value": 4154049
            },
            {
                "label": "Operating lease liability, net of current portion",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 18669643
            },
            {
                "label": "Operating lease liability, net of current portion",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 18670000
            },
            {
                "label": "Grant funding liability from affiliated entities",
                "concept": "ino:DeferredGrantFundingFromAffiliateCurrent",
                "unit": "usd",
                "value": 135000
            },
            {
                "label": "Short-term investments",
                "concept": "ShortTermInvestments",
                "unit": "usd",
                "value": 158535744
            },
            {
                "label": "Grant funding liability from affiliated entity, net of current portion",
                "concept": "ino:DeferredGrantFundingFromAffiliateNoncurrent",
                "unit": "usd",
                "value": 37500
            },
            {
                "label": "Total Inovio Pharmaceuticals, Inc. stockholders\u2019 equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 323903846
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 1205842585
            },
            {
                "label": "Accounts receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 7692944
            },
            {
                "label": "Total liabilities and stockholders\u2019 equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 437814047
            },
            {
                "label": "Operating lease liability",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 2264261
            },
            {
                "label": "Operating lease liability",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 2264000
            },
            {
                "label": "Investment in Geneos",
                "concept": "EquityMethodInvestments",
                "unit": "usd",
                "value": 957567
            },
            {
                "label": "Accounts payable and accrued expenses due to affiliated entities",
                "concept": "DueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 794928
            },
            {
                "label": "Total stockholders\u2019 equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 324000115
            },
            {
                "label": "Total stockholders\u2019 equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 324000115
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 3283540
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 3300000.0
            },
            {
                "label": "Deferred revenue from affiliated entities",
                "concept": "ino:ContractWithCustomerLiabilityAffiliatedEntityCurrent",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 31563697
            },
            {
                "label": "Other liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 39776
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 41263167
            },
            {
                "label": "Grant funding liability",
                "concept": "ino:DeferredGrantFundingCurrent",
                "unit": "usd",
                "value": 8616622
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "AccountsPayableAndAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 23533298
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 178700434
            },
            {
                "label": "Prepaid expenses and other current assets from affiliated entities",
                "concept": "ino:PrepaidExpensesAndOtherCurrentAssetsFromAffiliatedEntity",
                "unit": "usd",
                "value": 70543
            },
            {
                "label": "Total liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 113813932
            },
            {
                "label": "Derivative liability",
                "concept": "DerivativeLiabilities",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 10513371
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 10513371
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 437814047
            },
            {
                "label": "Common stock",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 167527
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -881858432
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -881900000.0
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 17641755
            },
            {
                "label": "Non-controlling interest",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": 96269
            },
            {
                "label": "Accounts receivable from affiliated entities",
                "concept": "AccountsReceivableRelatedPartiesCurrent",
                "unit": "usd",
                "value": 501311
            },
            {
                "label": "Deferred revenue",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 77878
            },
            {
                "label": "Accumulated other comprehensive income (loss)",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -247834
            },
            {
                "label": "Accrued clinical trial expenses",
                "concept": "ino:AccruedClinicalTrialExpenseCurrent",
                "unit": "usd",
                "value": 5841180
            },
            {
                "label": "Preferred stock",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Deferred revenue, net of current portion",
                "concept": "ContractWithCustomerLiabilityNoncurrent",
                "unit": "usd",
                "value": 82927
            },
            {
                "label": "Operating lease right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 13008571
            },
            {
                "label": "Deferred tax liabilities",
                "concept": "DeferredIncomeTaxLiabilitiesNet",
                "unit": "usd",
                "value": 32046
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 377064673
            }
        ],
        "cf": [
            {
                "label": "Proceeds from sale or maturity of investments",
                "concept": "ProceedsFromSaleOfShortTermInvestments",
                "unit": "usd",
                "value": 61263665
            },
            {
                "label": "Accounts payable and accrued expenses due to affiliated entities",
                "concept": "IncreaseDecreaseInAccountsPayableRelatedParties",
                "unit": "usd",
                "value": 287609
            },
            {
                "label": "Acquisition of non-controlling interest",
                "concept": "ProceedsFromMinorityShareholders",
                "unit": "usd",
                "value": 2379969
            },
            {
                "label": "Net unrealized gain on available-for-sale equity securities",
                "concept": "EquitySecuritiesFvNiUnrealizedGain",
                "unit": "usd",
                "value": 624522
            },
            {
                "label": "Grant funding liability from affiliated entities",
                "concept": "ino:IncreaseDecreaseinDeferredGrantFundingFromAffiliateCurrent",
                "unit": "usd",
                "value": -670925
            },
            {
                "label": "Right-of-use assets obtained in exchange for lease obligations",
                "concept": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Non-cash interest expense",
                "concept": "ino:NonCashInterestExpense",
                "unit": "usd",
                "value": 3019780
            },
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 2323505
            },
            {
                "label": "Costs related to issuance of convertible senior notes and convertible bonds",
                "concept": "PaymentsOfDebtIssuanceCosts",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from issuance of common stock, net of issuance costs",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 329960855
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 338340340
            },
            {
                "label": "Loss (gain) on short-term investments",
                "concept": "GainLossOnInvestments",
                "unit": "usd",
                "value": -571778
            },
            {
                "label": "Purchases of investments",
                "concept": "PaymentsToAcquireShortTermInvestments",
                "unit": "usd",
                "value": 153135274
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": 14969731
            },
            {
                "label": "Decrease in cash resulting from the deconsolidation of Geneos",
                "concept": "CashDivestedFromDeconsolidation",
                "unit": "usd",
                "value": 2774851
            },
            {
                "label": "Proceeds from stock option exercises",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 9856073
            },
            {
                "label": "Stock-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 11822483
            },
            {
                "label": "Non-cash lease expense",
                "concept": "ino:OperatingLeaseNonCashLeaseExpense",
                "unit": "usd",
                "value": 774438
            },
            {
                "label": "Grant funding liability",
                "concept": "ino:IncreaseDecreaseinDeferredGrantFundingCurrent",
                "unit": "usd",
                "value": 2551410
            },
            {
                "label": "Interest paid",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 4614662
            },
            {
                "label": "Operating lease right-of-use assets and liabilities, net",
                "concept": "ino:IncreaseDecreaseInOperatingLeaseRightOfUseAssetLeaseLiabilityNet",
                "unit": "usd",
                "value": -1550860
            },
            {
                "label": "Taxes paid related to net share settlement of equity awards",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 4028177
            },
            {
                "label": "Accrued clinical trial expenses",
                "concept": "ino:IncreaseDecreaseInAccruedClinicalTrialExpense",
                "unit": "usd",
                "value": 1853216
            },
            {
                "label": "Settlement of receivable with shares of common stock from affiliated entity (PLS)",
                "concept": "ino:SettlementOfReceivableWithSharesOfCommonStockFromEquitySecurity",
                "unit": "usd",
                "value": 1713770
            },
            {
                "label": "Other liabilities",
                "concept": "IncreaseDecreaseInOtherOperatingLiabilities",
                "unit": "usd",
                "value": 2833
            },
            {
                "label": "Amounts accrued for purchases of property and equipment",
                "concept": "IncreaseDecreaseInOtherAccruedLiabilities",
                "unit": "usd",
                "value": 198761
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 6992871
            },
            {
                "label": "Prepaid expenses and other current assets from affiliated entities",
                "concept": "ino:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssetsFromAffiliatedEntity",
                "unit": "usd",
                "value": -409996
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": 5383268
            },
            {
                "label": "Effect of exchange rate changes on cash and cash equivalents",
                "concept": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "unit": "usd",
                "value": 6184
            },
            {
                "label": "Proceeds from issuance of convertible senior notes and convertible bonds",
                "concept": "ProceedsFromIssuanceOfLongTermDebt",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net cash used in investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -55079630
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 30055813
            },
            {
                "label": "Amortization of premiums on investments",
                "concept": "ino:InterestIncomeAccruedOnShortTermInvestmentsCertificatesOfDeposit",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Deferred revenue from affiliated entities",
                "concept": "ino:IncreaseDecreaseInDeferredRevenueFromRelatedParties",
                "unit": "usd",
                "value": -31775
            },
            {
                "label": "Increase (Decrease) in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": 156504337
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -143136534
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -143136534
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -143136534
            },
            {
                "label": "Change in fair value of derivative liability",
                "concept": "IncreaseDecreaseInDerivativeLiabilities",
                "unit": "usd",
                "value": 75670977
            },
            {
                "label": "Proceeds from Geneos issuance of note payable",
                "concept": "ProceedsFromNotesPayable",
                "unit": "usd",
                "value": 171620
            },
            {
                "label": "Accounts receivable from affiliated entities",
                "concept": "IncreaseDecreaseInAccountsReceivableRelatedParties",
                "unit": "usd",
                "value": -846894
            },
            {
                "label": "Proceeds from the sale of investment in GeneOne",
                "concept": "PaymentsForProceedsFromInvestments",
                "unit": "usd",
                "value": -40125418
            },
            {
                "label": "Unrealized transaction loss on foreign-currency denominated debt",
                "concept": "ForeignCurrencyTransactionGainLossBeforeTax",
                "unit": "usd",
                "value": 290602
            },
            {
                "label": "Amortization of intangible assets",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 410311
            },
            {
                "label": "Amortization of intangible assets",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 410000
            },
            {
                "label": "Gain on deconsolidation of Geneos",
                "concept": "DeconsolidationGainOrLossAmount",
                "unit": "usd",
                "value": 4121075
            },
            {
                "label": "Gain on deconsolidation of Geneos",
                "concept": "DeconsolidationGainOrLossAmount",
                "unit": "usd",
                "value": 4121075
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -126762557
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInContractWithCustomerLiability",
                "unit": "usd",
                "value": -33115
            },
            {
                "label": "Share of net loss in Geneos",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -2661431
            },
            {
                "label": "Share of net loss in Geneos",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -2661431
            },
            {
                "label": "(Gain) loss on equity investment in affiliated entities",
                "concept": "ino:ChangeInValueOfInvestmentsInAffiliatedCompany",
                "unit": "usd",
                "value": 36250341
            },
            {
                "label": "(Gain) loss on equity investment in affiliated entities",
                "concept": "ino:ChangeInValueOfInvestmentsInAffiliatedCompany",
                "unit": "usd",
                "value": 36250341
            },
            {
                "label": "Tax benefit from other unrealized gains on short-term investments",
                "concept": "ino:TaxBenefitFromUnrealizedGainsLossesOnShortTermInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Purchases of capital assets",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 558588
            }
        ],
        "ic": [
            {
                "label": "Income tax benefit",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Interest income",
                "concept": "InterestIncomeOperating",
                "unit": "usd",
                "value": 2380678
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 67942875
            },
            {
                "label": "Change in fair value of derivative liability",
                "concept": "EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet",
                "unit": "usd",
                "value": -75670977
            },
            {
                "label": "Share in net loss of Geneos",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -2661431
            },
            {
                "label": "Share in net loss of Geneos",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -2661431
            },
            {
                "label": "Net income (loss) before income tax benefit and share in net loss of Geneos",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -140475103
            },
            {
                "label": "Basic (in dollars per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": -0.96
            },
            {
                "label": "Basic (in dollars per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": -0.96
            },
            {
                "label": "Net loss attributable to non-controlling interest",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -1063757
            },
            {
                "label": "Other income (expense), net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -714246
            },
            {
                "label": "Gain (loss) on investment in affiliated entities",
                "concept": "ino:ChangeInValueOfInvestmentsInAffiliatedCompany",
                "unit": "usd",
                "value": 36250341
            },
            {
                "label": "Gain (loss) on investment in affiliated entities",
                "concept": "ino:ChangeInValueOfInvestmentsInAffiliatedCompany",
                "unit": "usd",
                "value": 36250341
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 28630370
            },
            {
                "label": "Net unrealized gain on available-for-sale equity securities",
                "concept": "EquitySecuritiesFvNiUnrealizedGainLoss",
                "unit": "usd",
                "value": 624522
            },
            {
                "label": "Net unrealized gain on available-for-sale equity securities",
                "concept": "EquitySecuritiesFvNiUnrealizedGainLoss",
                "unit": "usd",
                "value": 625000
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 7634442
            },
            {
                "label": "Basic (in shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 148656454
            },
            {
                "label": "Basic (in shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 148656454
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -143136534
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -143136534
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -143136534
            },
            {
                "label": "Net income (loss) attributable to Inovio Pharmaceuticals, Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -142072777
            },
            {
                "label": "Net income (loss) attributable to Inovio Pharmaceuticals, Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -142100000.0
            },
            {
                "label": "Net income (loss) attributable to Inovio Pharmaceuticals, Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -142072777
            },
            {
                "label": "Diluted (in dollars per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": -0.96
            },
            {
                "label": "Diluted (in dollars per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": -0.96
            },
            {
                "label": "Gain on deconsolidation of Geneos",
                "concept": "DeconsolidationGainOrLossAmount",
                "unit": "usd",
                "value": 4121075
            },
            {
                "label": "Gain on deconsolidation of Geneos",
                "concept": "DeconsolidationGainOrLossAmount",
                "unit": "usd",
                "value": 4121075
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -94742606
            },
            {
                "label": "Diluted (in shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 148656454
            },
            {
                "label": "Diluted (in shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 148656454
            },
            {
                "label": "Total operating expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 96573245
            },
            {
                "label": "Total revenues",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 1830639
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -143136534
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -143136534
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -143136534
            },
            {
                "label": "Foreign currency translation",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": 6184
            },
            {
                "label": "Comprehensive loss attributable to non-controlling interest",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -1063757
            },
            {
                "label": "Unrealized gain (loss) on short-term investments, net of tax",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -726626
            },
            {
                "label": "Comprehensive income (loss) attributable to Inovio Pharmaceuticals, Inc.",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -142793219
            },
            {
                "label": "Comprehensive income (loss)",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -143856976
            }
        ]
    }
}